Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease

Abstract

In trials using tau PET as the outcome, plasma p-tau217 with tau PET may prove optimal for enrichment in preclinical and prodromal AD. However, plasma p-tau217 was most important in preclinical AD, while tau PET was more important in prodromal AD.